International Business Machines Corporation (IBM)

IBM's stock closed at $248.22 after a 1.51% gain in the latest session, and it is holding just above both its 200-day average ($247.25) and its 50-day average ($237.51). The stock is 25.34% below its 52-week high of $332.46 and 24.61% above its 52-week low of $199.19. Analysts are broadly supportive, with 12 of 25 rating it Buy and a median 12-month target of $265.00, while the stock's valuation sits well below its sector. The coming weeks will test whether the price can hold its moving-average support and whether revenue growth, which has slowed sharply, can recover.

IBM has beaten its EPS estimate in seven of the last eight reports and matched it once, on July 22, 2026. The most recent beat came on October 21, 2026, when adjusted EPS of $2.95 topped the $2.87 estimate by 2.79%, and the stock rose 0.26% in the first session afterward. The reaction pattern is less consistent than the beats: the share price was lower in the first session after four of the eight reports, higher after four, and after the April 22, 2026 report it fell 8.25%. The largest one-day move in that record came on January 29, 2025, when the stock gained 12.96% after an EPS beat of 3.70%. Investors have therefore rewarded IBM for beating estimates in some quarters and sold it in others, so a beat alone has not set the direction of the stock.

Revenue grew 1.09% in the latest quarter compared with the same quarter a year earlier, against a sector median of 24.2%, a gap of 23.1 percentage points. That is the factor that weighs most on the CleaRank score. Analysts still expect revenue to rise 4.5% to $70.6B this fiscal year, so the expected acceleration depends on growth picking up from the latest quarter's pace. Profitability is a strength: the net profit margin is 16.0%, the operating margin 18.38%, and return on equity 34.77% against a sector median of 13.4%. Debt-to-equity of 1.85 is the figure to watch on the balance sheet.

At a trailing P/E of 21.18, IBM trades 55.8% below the sector median P/E of 35.1, and its price-to-sales ratio of 3.36 is 55.3% below the sector median of 7.6. Its trailing dividend yield is 2.72%, with an annual dividend of $6.74 per share. On October 22, 2026, Jefferies, Citigroup and Barclays kept Buy or Overweight ratings, while UBS, Morgan Stanley and BMO Capital kept Neutral, Equal-Weight and Market Perform ratings. Across 25 analysts, 12 rate the stock buy or strong buy, 11 hold it and 2 sell it. Three months ago 13 of 25 were buy ratings, so the number of buy ratings has slipped. Insider activity over the last 18 months totals $5.8M in sales from one transaction, against $417K of open-market purchases from three transactions.

The base case is that IBM trades in a range near its moving averages while the market judges whether its earnings beats can turn into faster top-line growth. Analysts expect EPS to rise 7.2% this fiscal year to $12.42 and 6.6% next year to $13.23, and expect revenue to grow 4.5% to $70.6B, which would be a clear acceleration only if it is delivered. A move toward the median analyst target of $265.00 would need the price to clear the 52-week-high area of $332.46 only if sentiment improves sharply; the lowest target of $174.00 shows how far some analysts see downside if growth stalls. The stock's beta of 0.76 and a typical daily move of 1.56% suggest a steadier path than the broader market, though this is a description of past volatility, not a forecast.

Support sits first at $247.25, the 200-day simple moving average, which the price is only slightly above. Below it is the 20-day exponential moving average at $245.99, which is the next short-term marker a pullback would meet. Further down, the 50-day simple moving average at $237.51 marks medium-term support, and the 52-week low of $199.19 is the deepest floor on the chart. On the upside, the 52-week high of $332.46 is the nearest resistance level above the price and the level a sustained rally would have to reach.